Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2011, Article ID 905734, 7 pages
http://dx.doi.org/10.4061/2011/905734
Research Article

Free Thyroxine Level in the High Normal Reference Range Prescribed for Nonpregnant Women May Reduce the Preterm Delivery Rate in Multiparous

1Praxis für Gynäkologie und Geburtshilfe, Marktplatz 29, 88416 Ochsenhausen, Germany
2Frauenklinik des Klinikums Memmingen, Klinikum Memmingen, Bismarckstraße 23, 87700 Memmingen, Germany
3Institut Forschung, Beratung und Evaluation, FB+E Forschung, Beratung Evaluation GmbH, Postfach 10 03 35, 10563 Berlin, Germany

Received 18 August 2011; Revised 23 October 2011; Accepted 24 October 2011

Academic Editor: Noriyuki Koibuchi

Copyright © 2011 P. Torremante et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Goldenberg, J. F. Culhane, J. D. Iams, and R. Romero, “Epidemiology and causes of preterm birth,” The Lancet, vol. 371, no. 9606, pp. 75–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Tucker and W. McGuire, “Epidemiology of preterm birth,” British Medical Journal, vol. 329, no. 7467, pp. 675–678, 2004. View at Google Scholar · View at Scopus
  3. J. Langhoff-Roos, U. Kesmodel, B. Jacobsson, S. Rasmussen, and I. Vogel, “Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study,” British Medical Journal, vol. 332, no. 7547, pp. 937–939, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. M. Slattery and J. J. Morrison, “Preterm delivery,” Lancet, vol. 360, no. 9344, pp. 1489–1497, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. W. M. Callaghan, M. F. MacDorman, S. A. Rasmussen, C. Qin, and E. M. Lackritz, “The contribution of preterm birth to infant mortality rates in the United States,” Pediatrics, vol. 118, no. 4, pp. 1566–1573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. Menard, C. Mazouni, I. Salem-Cherif et al., “High vaginal concentrations of atopobium vaginae and gardnerella vaginalis in women undergoing preterm labor,” Obstetrics and Gynecology, vol. 115, no. 1, pp. 134–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. E. Hoekstra, T. B. Ferrara, R. J. Couser, N. R. Payne, and J. E. Connett, “Survival and long-term neurodevelopmental outcome of extremely premature infants born at 23–26 weeks' gestational age at a tertiary center,” Pediatrics, vol. 113, no. 1, pp. E1–E6, 2004. View at Google Scholar · View at Scopus
  8. A. L. Den Ouden, J. H. Kok, P. H. Verkerk, R. Brand, and S. P. Verloove-Vanhorick, “The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants,” Pediatric Research, vol. 39, no. 1, pp. 142–145, 1996. View at Google Scholar · View at Scopus
  9. R. Z. Klein, J. D. Sargent, P. R. Larsen, S. E. Waisbren, J. E. Haddow, and M. L. Mitchell, “Relation of severity of maternal hypothyroidism to cognitive development of offspring,” Journal of Medical Screening, vol. 8, no. 1, pp. 18–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. E. P. Kasatkina, L. N. Samsonova, V. N. Ivakhnenko et al., “Gestational hypothyroxinemia and cognitive function in offspring,” Neuroscience and Behavioral Physiology, vol. 36, no. 6, pp. 619–624, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. P. O. D. Pharoah, K. J. Connolly, R. P. Ekins, and A. G. Harding, “Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children,” Clinical Endocrinology, vol. 21, no. 3, pp. 265–270, 1984. View at Google Scholar · View at Scopus
  12. J. Henrichs, J. J. Bongers-Schokking, J. J. Schenk et al., “Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. 4227–4234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Costeira, P. Oliveira, N. C. Santos et al., “Psychomotor development of children from an iodine-deficient region,” Journal of Pediatrics, vol. 159, no. 3, pp. 447–453, 2011. View at Publisher · View at Google Scholar
  14. N. Ohara, T. Tsujino, and T. Maruo, “The role of thyroid hormone in trophoblast function, early pregnancy maintenance, and fetal neurodevelopment,” Journal of Obstetrics and Gynaecology Canada, vol. 26, no. 11, pp. 982–990, 2004. View at Google Scholar · View at Scopus
  15. R. Negro, G. Formoso, T. Mangieri, A. Pezzarossa, D. Dazzi, and H. Hassan, “Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 7, pp. 2587–2591, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Ausó, R. Lavado-Autric, E. Cuevas, F. Escobar Del Rey, G. Morreale De Escobar, and P. Berbel, “A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration,” Endocrinology, vol. 145, no. 9, pp. 4037–4047, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. B. M. Casey and K. J. Leveno, “Thyroid disease in pregnancy,” Obstetrics and Gynecology, vol. 108, no. 5, pp. 1283–1292, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Ferretti, L. Persani, M. L. Jaffrain-Rea, S. Giambona, G. Tamburrano, and P. Beck-Peccoz, “Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 3, pp. 924–929, 1999. View at Google Scholar · View at Scopus
  19. M. Slawik, B. Klawitter, E. Meiser et al., “Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 11, pp. 4115–4122, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Lania, L. Persani, and P. Beck-Peccoz, “Central hypothyroidism,” Pituitary, vol. 11, no. 2, pp. 181–186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. B. M. Casey, J. S. Dashe, C. Y. Spong, D. D. McIntire, K. J. Leveno, and G. F. Cunningham, “Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy,” Obstetrics and Gynecology, vol. 109, no. 5, pp. 1129–1135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Cleary-Goldman, F. D. Malone, G. Lambert-Messerlian et al., “Maternal thyroid hypofunction and pregnancy outcome,” Obstetrics and Gynecology, vol. 112, no. 1, pp. 85–92, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. H. A. Oliveira, E. R. Barbosa, T. Kasamatsu, and J. Abucham, “Evidence for thyroid hormone as a positive regulator of serum thyrotropin bioactivity,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 8, pp. 3108–3113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. G. M. de Escobar, M. J. Obregon, and F. E. del Rey, “Clinical perspective: is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 11, pp. 3975–3987, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. G. M. de Escobar, M. J. Obregón, and F. Escobar del Rey, “Maternal thyroid hormones early in prenancy and fetal brain development,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 18, no. 2, pp. 225–248, 2004. View at Publisher · View at Google Scholar
  26. J. H. Goodman and M. E. Gilbert, “Modest thyroid hormone insufficiency during development induces a cellular malformation in the corpus callosum: a model of cortical dysplasia,” Endocrinology, vol. 148, no. 6, pp. 2593–2597, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Lavado-Autric, E. Ausó, J. V. García-Velasco et al., “Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny,” Journal of Clinical Investigation, vol. 111, no. 7, pp. 1073–1082, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Gyamfi, R. J. Wapner, and M. E. D'Alton, “Thyroid dysfunction in pregnancy: the basic science and clinical evidence surrounding the controversy in management,” Obstetrics and Gynecology, vol. 113, no. 3, pp. 702–707, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Li, Z. Shan, W. Teng et al., “Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25–30 months,” Clinical Endocrinology, vol. 72, no. 6, pp. 825–829, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. B. J. Smit, J. H. Kok, T. Vulsma, J. M. Briet, K. Boer, and W. M. Wiersinga, “Neurologic development of the newborn and young child in relation to maternal thyroid function,” Acta Paediatrica, vol. 89, no. 3, pp. 291–295, 2000. View at Google Scholar · View at Scopus
  31. A. K. Sinha, M. R. Pickard, and R. P. Ekins, “Maternal hypothyroxinemia and brain development: I. A hypothetical control system governing fetal exposure to maternal thyroid hormones,” Acta Medica Austriaca, vol. 19, supplement 1, pp. 40–48, 1992. View at Google Scholar · View at Scopus
  32. L. Kooistra, S. Crawford, A. L. Van Baar, E. P. Brouwers, and V. J. Pop, “Neonatal effects of maternal hypothyroxinemia during early pregnancy,” Pediatrics, vol. 117, no. 1, pp. 161–167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. V. J. Pop, E. P. Brouwers, H. L. Vader, T. Vulsma, A. L. Van Baar, and J. J. De Vijlder, “Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study,” Clinical Endocrinology, vol. 59, no. 3, pp. 282–288, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. V. J. Pop, J. L. Kuijpens, A. L. Van Baar et al., “Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy,” Clinical Endocrinology, vol. 50, no. 2, pp. 149–155, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. H. A. Wijnen, L. Kooistra, H. L. Vader, G. G. Essed, B. W. Mol, and V. J. Pop, “Maternal thyroid hormone concentration during late gestation is associated with foetal position at birth,” Clinical Endocrinology, vol. 71, no. 5, pp. 746–751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Obregon, R. Calvo, F. E. del Rey, and G. M. de Escobar, “Ontogenesis of thyroid function and interactions with maternal function,” Endocrine Development, vol. 10, pp. 86–98, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Oken, L. E. Braverman, D. Platek, M. L. Mitchell, S. L. Lee, and E. N. Pearce, “Neonatal thyroxine, maternal thyroid function, and child cognition,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, pp. 497–503, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. W. M. Wiersinga, “Thyroid hormone replacement therapy,” Hormone Research, vol. 56, no. 1, pp. 74–81, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Helfand and L. M. Crapo, “Monitoring therapy in patients taking levothyroxine,” Annals of Internal Medicine, vol. 113, no. 6, pp. 450–454, 1990. View at Google Scholar · View at Scopus
  40. B. Bakker, M. J. E. Kempers, J. J. M. De Vijlder et al., “Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism,” Clinical Endocrinology, vol. 57, no. 4, pp. 529–537, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. J. H. Metsman, “Hyperthyroidism in pregnancy,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 18, no. 2, pp. 267–288, 2004. View at Publisher · View at Google Scholar
  42. F. Pacini, M. Schlumberger, H. Dralle et al., “European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium,” European Journal of Endocrinology, vol. 154, no. 6, pp. 787–803, 2006. View at Publisher · View at Google Scholar
  43. A. Mortoglou and Candiloros H, “The serum triiodothyronine to thyroxine (T3/T4) ratio in various thyroid disorders and after Levothyroxine replacement therapy,” Hormones, vol. 3, pp. 120–126, 2004. View at Google Scholar
  44. D. Salvatore, H. Tu, J. W. Harney, and P. R. Larsen, “Type 2 iodothyronine deiodinase is highly expressed in human thyroid,” Journal of Clinical Investigation, vol. 98, no. 4, pp. 962–968, 1996. View at Google Scholar · View at Scopus
  45. P. Laurberg, H. Vestergaard, S. Nielsen et al., “Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2149–2156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. W. M. Wiersinga, “Thyroid hormone replacement therapy,” Hormone Research, vol. 56, no. 1, pp. 74–81, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Jonklaas, B. Davidson, S. Bhagat, and S. J. Soldin, “Triiodothyronine levels in athyreotic individuals during levothyroxine therapy,” Journal of the American Medical Association, vol. 299, no. 7, pp. 769–777, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Miyauchi, Y. Takamura, Y. Ito et al., “3,5,3′-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 6, pp. 2239–2242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. V. V. Fadeyev, T. B. Morgunova, J. P. Sytch, and G. A. Melnichenko, “TSH and thyroid hormones concentrations in patients with hypothyroidism receiving replacement therapy with L-thyroxine alone or in combination with L-triiodothyronine,” Hormones, vol. 4, no. 2, pp. 101–107, 2005. View at Google Scholar · View at Scopus
  50. K. A. Woeber, “Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations,” Journal of Endocrinological Investigation, vol. 25, no. 2, pp. 106–109, 2002. View at Google Scholar · View at Scopus
  51. C. J. Pearce and R. L. Himsworth, “Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine,” British Medical Journal, vol. 288, no. 6418, pp. 693–695, 1984. View at Google Scholar · View at Scopus
  52. K. Liewendahl, T. Helenius, B. A. Lamberg, H. Mahonen, and G. Wagar, “Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy,” Acta Endocrinologica, vol. 116, no. 3, pp. 418–424, 1987. View at Google Scholar · View at Scopus
  53. J. F. Iverson and C. N. Mariash, “Optimal free thyroxine levels for thyroid hormone replacement in hypothyroidism,” Endocrine Practice, vol. 14, no. 5, pp. 550–555, 2008. View at Google Scholar · View at Scopus
  54. P. Laurberg, C. Bournaud, J. Karmisholt, and J. Orgiazzi, “Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy,” European Journal of Endocrinology, vol. 160, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Ishihara, M. Nishikawa, K. Ikekubo et al., “Thyroxine (T4) metabolism in an athyreotic patient who had taken a large amount of T4 at one time,” Endocrine Journal, vol. 45, no. 3, pp. 371–375, 1998. View at Google Scholar · View at Scopus
  56. S. H. Mandel, A. R. Magnusson, B. T. Burton, J. R. Swanson, and S. H. LaFranchi, “Massive levothyroxine ingestion. Conservative management,” Clinical Pediatrics, vol. 28, no. 8, pp. 374–376, 1989. View at Google Scholar · View at Scopus
  57. J. B. Williams, “Adverse effects of thyroid hormones,” Drugs and Aging, vol. 11, no. 6, pp. 460–469, 1997. View at Google Scholar · View at Scopus
  58. A. L. Mitchell, B. Hickey, J. L. Hickey, and S. H. S. Pearce, “Trends in thyroid hormone prescribing and consumption in the UK,” BMC Public Health, vol. 9, article 132, 2009. View at Publisher · View at Google Scholar · View at Scopus